Current Protein Identity:Q6MZV7 New Search
Main Difference Dimensions in This Set
Different construct Different mutation/modification Different assembly state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
5NSC Fc DEKK heterodimer variant Deposited 2017-04-26 Assembly 1 Other combination Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 242–473(232 aa)
Chain B 242–473(232 aa)
Mutation:L351K, T366K Mutation:L351D, L368E GOL GLYCEROL × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;291 K;0.2 M sodium fluoride, 20% w/v PEG3350
Resolution 2.30 Å R-free 0.265
5NSG Fc DEDE homodimer variant Deposited 2017-04-26 Assembly 1 Other combination Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 242–473(232 aa)
Mutation:L351D, L368E ZN ZINC ION × 6 ACT ACETATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 4.5;291 K;acetate buffer pH 4.5, 0.2 M zinc acetate, 16% w/v PEG 3000
Resolution 2.22 Å R-free 0.243
5U4Y IgG Fc bound to 3 helix of the B-domain from Protein A Deposited 2016-12-06 Assembly 1 Other combination Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 261–472(212 aa) Fragment:unp residues 261-472
Chain B 261–472(212 aa) Fragment:unp residues 261-472
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7;293 K;25% PEG 3400, 0.1M magnesium acetate, 0.1 M HEPES pH 7.0. Protein concentration 5mg/mL.
Resolution 2.50 Å R-free 0.230
5U52 2 helix minimized version of the B-domain from Protein A (Z34C0 bound to IgG1 Fc (monoclinic form) Deposited 2016-12-06 Assembly 1 Other combination Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 262–469(208 aa) Fragment:unp residues 262-469
Chain B 262–469(208 aa) Fragment:unp residues 262-469
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;20% PEG monomethyl ether 550, 0.1M bis-tris propane pH 6.5, 0.1M NaCl, 5mg/mL protein concentration.
Resolution 1.94 Å R-free 0.228
5U66 Modified single helix from the B-domain of protein A bound to IgG1 Fc Deposited 2016-12-07 Assembly 1 Other combination Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 263–469(207 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7.2;293 K;20% PEG 4000, 0.1M HEPES pH 7.2, 5mg/mL protein concentration.
Resolution 1.70 Å R-free 0.227
5VME Crystal structure of human IgG1 Fc K248E, T437R mutant Deposited 2017-04-27 Assembly 1 Other combination Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 251–473(223 aa)
Chain B 251–473(223 aa)
Mutation:K248, T437R Mutation:K248, T437R No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;35.5% PEG 300, 0.1 M HEPES, pH 7.0
Resolution 3.10 Å R-free 0.285
6CHF Crystal structure of a Fc fragment LALA mutant (L234A, L235A) of human IgG1 (crystal form 1) Deposited 2018-02-22 Assembly 1 Other combination Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 260–473(214 aa)
Chain B 260–473(214 aa)
Mutation:L234A L235A Mutation:L234A L235A No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;294 K;20% PEG MME 5,000 0.1 M Bis-Tris pH 6.5
Resolution 2.40 Å R-free 0.273
6CJC CRYSTAL STRUCTURE OF A FC FRAGMENT LALA MUTANT (L234A, L235A) OF HUMAN IGG1 (CRYSTAL FORM 3) Deposited 2018-02-26 Assembly 1 Other combination Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 260–473(214 aa)
Chain B 260–473(214 aa)
Mutation:L234A, L235A Mutation:L234A, L235A CL CHLORIDE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;294 K;20% PEG MME 5,000 0.1 M Bis-Tris. pH 6.5
Resolution 2.58 Å R-free 0.241
6CJX Crystal structure of a Fc fragment LALA mutant (L234A, L235A) of human IgG1 (crystal form 2) Deposited 2018-02-27 Assembly 1 Other combination Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 260–473(214 aa)
Chain B 260–473(214 aa)
Mutation:L234A, L235A Mutation:L234A, L235A No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;294 K;25% PEG 3,350 0.1 M Bus-Tris pH 6.5
Resolution 2.44 Å R-free 0.264
6N9T Structure of a peptide-based photo-affinity cross-linker with Herceptin Fc Deposited 2018-12-04 Assembly 1 Other combination Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 249–472(224 aa) Fragment:residues 249-472
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.6;291 K;100mM sodium acetate pH=5.6, 12%(w/v) PEG 1000
Resolution 2.58 Å R-free 0.265
6N9T Structure of a peptide-based photo-affinity cross-linker with Herceptin Fc Deposited 2018-12-04 Assembly 2 Other combination Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 249–472(224 aa) Fragment:residues 249-472
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.6;291 K;100mM sodium acetate pH=5.6, 12%(w/v) PEG 1000
Resolution 2.58 Å R-free 0.265
6P6D HUMAN IGG1 FC FRAGMENT, C239 INSERTION MUTANT Deposited 2019-06-03 Assembly 1 Other combination Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 247–473(227 aa)
Chain B 247–473(227 aa)
Mutation:C239 insertion Mutation:C239 insertion CYS CYSTEINE × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7.5;295 K;12 mg/mL protein, 20% w/v PEG 3350, 200 mM K Acetate
Resolution 2.31 Å R-free 0.268
7LF5 Structure of Hyperglycosylated Human IgG1 Fc (Fc267) Deposited 2021-01-15 Assembly 1 Other combination Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 242–473(232 aa)
Not recorded FUC alpha-L-fucopyranose × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;298 K;CRYSTALS GROWN BY MIXING 1 UL OF FC267 (10 MG/ML IN 10mM HEPES, 75mM NaCl pH 7.4) WITH 1 UL OF PRECIPITANT SOLUTION CONSISTING OF 0.1M HEPES pH 6.5, 8% w/v PEG6000
Resolution 2.60 Å R-free 0.243
7LF9 Structure of Hyperglycosylated Human IgG1 Fc (Fc329) Deposited 2021-01-15 Assembly 1 Other combination Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 242–473(232 aa)
Chain B 242–473(232 aa)
Not recorded FUC alpha-L-fucopyranose × 2 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;298 K;CRYSTALS GROWN BY MIXING 1 UL OF FC329 (10 MG/ML IN 10mM HEPES, 75mM NaCl pH 7.4) WITH 1 UL OF PRECIPITANT SOLUTION CONSISTING OF 0.1M HEPES pH 6.5, 12.571% w/v PEG6000
Resolution 2.20 Å R-free 0.246
7LFN Structure of Hyperglycosylated Human IgG1 Fc (Fc267_329) Deposited 2021-01-17 Assembly 1 Other combination Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 242–473(232 aa)
Chain B 242–473(232 aa)
Not recorded FUC alpha-L-fucopyranose × 2 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;298 K;CRYSTALS GROWN BY MIXING 1 UL OF FC267_329 (10 MG/ML IN 10mM HEPES, 75mM NaCl pH 7.4) WITH 1 UL OF PRECIPITANT SOLUTION CONSISTING OF 0.025M MES pH 7.0, 0.1M KCl, 20.571% w/v PEG3350
Resolution 2.60 Å R-free 0.270
7RHO Human IgG1 Fc fragment, hinge-free, expressed in E. coli Deposited 2021-07-18 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 263–473(211 aa) Fragment:engineered variant
Chain B 263–473(211 aa) Fragment:engineered variant
Not recorded EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 7;295 K;20% (w/v) PEG 6000, 40 mM CaCl2, 100 mM NaHepes
Resolution 2.00 Å R-free 0.270
7RHO Human IgG1 Fc fragment, hinge-free, expressed in E. coli Deposited 2021-07-18 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain D 263–473(211 aa) Fragment:engineered variant
Chain E 263–473(211 aa) Fragment:engineered variant
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 7;295 K;20% (w/v) PEG 6000, 40 mM CaCl2, 100 mM NaHepes
Resolution 2.00 Å R-free 0.270
7RHO Human IgG1 Fc fragment, hinge-free, expressed in E. coli Deposited 2021-07-18 Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain F 263–473(211 aa) Fragment:engineered variant
Chain G 263–473(211 aa) Fragment:engineered variant
Not recorded EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 7;295 K;20% (w/v) PEG 6000, 40 mM CaCl2, 100 mM NaHepes
Resolution 2.00 Å R-free 0.270
7RHO Human IgG1 Fc fragment, hinge-free, expressed in E. coli Deposited 2021-07-18 Assembly 4 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain J 263–473(211 aa) Fragment:engineered variant
Chain K 263–473(211 aa) Fragment:engineered variant
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION;pH 7;295 K;20% (w/v) PEG 6000, 40 mM CaCl2, 100 mM NaHepes
Resolution 2.00 Å R-free 0.270
8F8W Crystal structure of Nb.X0 bound to the afucosylated human IgG1 fragment crystal form I Deposited 2022-11-22 Assembly 1 Other combination Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 247–470(224 aa)
Chain B 247–470(224 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;0.1 M Sodium HEPES 7.5 20 % w/v PEG 8000. Cryopreserved with 12.5% glycerol.
Resolution 2.71 Å R-free 0.241
8F8W Crystal structure of Nb.X0 bound to the afucosylated human IgG1 fragment crystal form I Deposited 2022-11-22 Assembly 2 Other combination Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain E 247–470(224 aa)
Chain F 247–470(224 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;0.1 M Sodium HEPES 7.5 20 % w/v PEG 8000. Cryopreserved with 12.5% glycerol.
Resolution 2.71 Å R-free 0.241
8F8X Crystal structure of Nb.X0 bound to the afucosylated human IgG1 fragment crystal form II Deposited 2022-11-22 Assembly 1 Other combination Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 247–470(224 aa)
Chain B 247–470(224 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;293 K;20 % w/v PEG 6000, 0.1 M Sodium citrate 4.0, 0.2 M Lithium chloride. No additional cryoprotectant.
Resolution 2.60 Å R-free 0.285
8Q5U Endoglycosidase S2 in complex with IgG1 Fc Deposited 2023-08-09 Assembly 1 Other combination Heteromer;Protein × 6 PDB declaration: hexameric(6) Consistent with protein count
Chain A 247–473(227 aa)
Chain B 247–473(227 aa)
Chain C 247–473(227 aa)
Mutation:L234C E382A Mutation:L234C E382A Mutation:L234C E382A GOL GLYCEROL × 4 PGE TRIETHYLENE GLYCOL × 5 CA CALCIUM ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;298 K;Morpheus (Molecular Dimensions) conditon G12: 0.1 M carboxylic acids(0.2M Sodium formate; 0.2M Ammonium acetate; 0.2M Sodium citrate tribasic dihydrate; 0.2M Potassium sodium tartrate tetrahydrate; 0.2M Sodium oxamate); 0.1 M buffer system 3(Tris (base); BICINE); pH 8.5; 37.5 v/v Precipitant Mix 4 (25% v/v MPD; 25% PEG 1000; 25% w/v PEG 3350)
Resolution 3.00 Å R-free 0.252
9IUJ Integrin alpha-v beta-3 in complex with rhodostomin Deposited 2024-07-22 Assembly 1 Insufficient information Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 247–473(227 aa)
Chain B 247–473(227 aa)
Not recorded CA CALCIUM ION × 7 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 MG MAGNESIUM ION × 1 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.78 Å
9JEI Integrin alpha-v beta-3 in complex with Echistatin Deposited 2024-09-03 Assembly 1 Insufficient information Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 247–473(227 aa)
Chain B 247–473(227 aa)
Not recorded CA CALCIUM ION × 7 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 MG MAGNESIUM ION × 1 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 3.16 Å
9LT3 Integrin alpha-v beta-3 in complex with Trimucrin Deposited 2025-02-05 Assembly 1 Insufficient information Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 247–473(227 aa)
Chain B 247–473(227 aa)
Not recorded CA CALCIUM ION × 7 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 MG MAGNESIUM ION × 1 ELECTRON MICROSCOPY
cryo-EM buffer pH 7.4
cryo-EM vitrification conditions Cryogen ETHANE
Resolution 2.79 Å